资讯内容 Content

[CIT2010]再血管化治疗与糖尿病:来自近期临床试验的经验——Donald E. Cutlip教授专访
 编辑:国际循环网 时间:2010/4/1 10:25:00    加入收藏
 标签:专家访谈(专题)  关键字:糖尿病 血管化治疗 

<International Circulation>:ccording to a subgroup analysis from the multinational SYNTAX study recently published in JACC, for patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous coronary intervention (PCI) compared to surgery. Can you comment on this conclusion?

Donald E. Cutlip :I don’t think this is surprising.  Diabetes is a major risk factor for restenosis for both bare metal and drug-eluting stents.  In these high risk patients with multivessel disease these risks are even higher.  The real question is whether these risks translate to differences in mortality or myocardial infarction and possibly whether the risks might be stratified by lesion complexity (Syntax score) as was observed for the overall SYNTAX population.



[1]  [2]  [3]  下一页

欢迎:

网友评论仅供其表达个人看法,并不表明国际循环同意其观点或证实其描述。 发表评论需登陆

点击排行 Top Hits

 
关于本站 | 设为首页 | 加入收藏 | 站长邮箱 | 友情链接 | 版权申明

国际循环 版权所有  2008-2024 icirculation.com  All Rights Reserved